February 2009

27th February

Bayer AG
Plans to switch from bearer shares to registered shares
Bayer proposes increased dividend for 2008 of EUR 1.40 per share » more

18th February

Bayer Schering Pharma
Bayer Schering Pharma Receives Approval to Initiate Phase III Program for Investigational Pulmonary Hypertension Therapy
Based on the positive findings of the clinical development phase II trial, Bayer Schering Pharma has received ethical approval from the Cambridgeshire 1 Research Ethics Committee in the United Kingdom to begin the phase III program for its oral agent riociguat » more

17th February

Bayer MaterialScience
Peace and quiet in open-plan offices
Noisy open-plan offices could be a thing of the past, thanks to a range of designs for effective sound insulation and noise absorption developed by Bayer MaterialScience, in cooperation with SilenceSolutions in Cologne » more

3rd February

Bayer plc
Enrol now for the Bayer Newbury 10K 2009
Bayer has announced the date of this year's Bayer Newbury 10K run, organised in partnership with Newbury Athletic Club » more